| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Lu,Qian-San | Chairman | 1.57% | |
| Su,Zai-Ji | Director | 0.90% | |
| Yu,Kun-Xi | Director | 2.38% | |
| Xu,Liang-Zhong | Director | 17.59% | JI LI INVESTMENT CO., LTD. |
| Lai,Xin-Zhong | Independent Director | 0.00% | |
| Wang,Zhou-Zhen | Independent Director | 0.00% | |
| Li,Yong-Ting | Independent Director | 0.00% |
Change Company Name to JIYASHE CO., LTD. (FORMER NAME: JISHENG CO., LTD.)
2023/08/21
Change Company Name to GSEVEN CO., LTD.
2023/08/21
Change Company Name to JIYASHE CO., LTD. (FORMER NAME: JISHENG CO., LTD.)
2023/06/29
Change Company Name to GSEVEN CO., LTD.
2023/06/29
Change Company Name to JIYASHE CO., LTD. (FORMER NAME: JISHENG CO., LTD.)
2023/05/22
Change Company Name to GSEVEN CO., LTD.
2023/05/22
Change Company Name to JIYASHE CO., LTD. (FORMER NAME: JISHENG CO., LTD.)
2023/03/28
Change Company Name to GSEVEN CO., LTD.
2023/03/28
Change Company Name to GSEVEN CO., LTD.
2022/11/22
Change Company Name to JIYASHE CO., LTD. (FORMER NAME: JISHENG CO., LTD.)
2022/08/23
Change Capital to 600,000,000
2014/07/21
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 1,171,965 | 4,642,604 | 4,063,697 |
| Operating cost | 909,544 | 3,569,327 | 3,075,981 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 262,421 | 1,073,277 | 987,716 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 262,421 | 1,073,277 | 987,716 |
| Operating expenses | 216,244 | 876,790 | 847,234 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 46,177 | 196,487 | 140,482 |
| Non-operating income and expenses | 1,309 | -4,372 | 2,363 |
| Net profit (loss) before tax | 47,486 | 192,115 | 142,845 |
| Income tax expense (benefits) | 9,499 | 39,132 | 34,473 |
| Net profit (loss) of ongoing business for the current period | 37,987 | 152,983 | 108,372 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 37,987 | 152,983 | 108,372 |
| Other comprehensive profit (loss), net | - | 3,252 | 179 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 37,987 | 156,235 | 108,551 |
| Net profit (loss) attributable to owners of parent company | 37,987 | 152,983 | 108,372 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 37,987 | 156,235 | 108,551 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 3 | 2 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -40,104 | 309,968 | 37,706 |
| Net cash inflows (outflows) from investing activities | -8,774 | -104,100 | -117,510 |
| Net cash inflow (outflow) from financing activities | -52,066 | -140,351 | -36,139 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | -100,944 | 65,517 | -115,943 |
| Beginning balance of cash and cash equivalents | 314,384 | 248,867 | 364,810 |
| Ending balance of cash and cash equivalents | 213,440 | 314,384 | 248,867 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 2,103,361 | 2,626,595 | 2,442,113 |
| Non-current asset | 777,725 | 771,436 | 701,986 |
| Total asset | 2,881,086 | 3,398,031 | 3,144,099 |
| Current liability | 1,854,771 | 2,327,668 | 2,143,524 |
| Non-current liability | 40,246 | 43,114 | 50,394 |
| Total liability | 1,895,017 | 2,370,782 | 2,193,918 |
| share capital | 395,836 | 395,836 | 395,836 |
| Equity - secruity token | - | - | - |
| capital reserve | 136,138 | 136,138 | 136,138 |
| retained earning | 454,095 | 495,275 | 418,207 |
| Other equity | - | - | - |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 986,069 | 1,027,249 | 950,181 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 986,069 | 1,027,249 | 950,181 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 24 | 25 | 24 |
